Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
Christopher Allen, Robert K. Hills, Katarina Lamb, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1891-1901
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5160
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2451-2459
Open Access | Times Cited: 218
Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 429
Open Access | Times Cited: 194
Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse
Jason E. Farrar, Heather L. Schuback, Rhonda E. Ries, et al.
Cancer Research (2016) Vol. 76, Iss. 8, pp. 2197-2205
Open Access | Times Cited: 154
Acute myeloid leukemia: 2014 Update on risk‐stratification and management
Elihu H. Estey
American Journal of Hematology (2014) Vol. 89, Iss. 11, pp. 1063-1081
Open Access | Times Cited: 145
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
Friederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Blood (2019) Vol. 133, Iss. 10, pp. 1140-1151
Open Access | Times Cited: 121
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma
Chuanjie Zhang, Zongtai Li, Feng Qi, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 22, pp. 648-648
Open Access | Times Cited: 117
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology
Daniel A. Arber, Michael J. Borowitz, Melissa H. Cessna, et al.
Archives of Pathology & Laboratory Medicine (2017) Vol. 141, Iss. 10, pp. 1342-1393
Open Access | Times Cited: 105
Acute Myeloid Leukemia: The Good, the Bad, and the Ugly
Andrew Kuykendall, Nicolas Duployez, Nicolas Boissel, et al.
American Society of Clinical Oncology Educational Book (2018), Iss. 38, pp. 555-573
Closed Access | Times Cited: 101
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
Peter Paschka, Richard F. Schlenk, Daniela Weber, et al.
Leukemia (2018) Vol. 32, Iss. 7, pp. 1621-1630
Closed Access | Times Cited: 97
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, et al.
Blood Advances (2020) Vol. 4, Iss. 1, pp. 66-75
Open Access | Times Cited: 86
Core binding factor acute myelogenous leukemia-2021 treatment algorithm
Gautam Borthakur, Hagop M. Kantarjian
Blood Cancer Journal (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 78
Role and Significance of c-KIT Receptor Tyrosine Kinase in Cancer: A Review
Emana Sheikh, Tony Tran, Semir Vranić, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 62
Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia
Shunjie Yu, Sen Yang, Lijuan Hu, et al.
Annals of Hematology (2025)
Open Access | Times Cited: 1
Prognostic factors for acute myeloid leukaemia in adults - biological significance and clinical use
Rüediger Liersch, Carsten Müller‐Tidow, Wolfgang E. Berdel, et al.
British Journal of Haematology (2014) Vol. 165, Iss. 1, pp. 17-38
Closed Access | Times Cited: 95
The importance ofFLT3mutational analysis in acute myeloid leukemia
Mrinal M. Patnaik
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 59, Iss. 10, pp. 2273-2286
Open Access | Times Cited: 83
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia
John P. Leonard, Peter Martin, Gail J. Roboz
Journal of Clinical Oncology (2017) Vol. 35, Iss. 23, pp. 2708-2715
Closed Access | Times Cited: 77
Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia
Hossein Ayatollahi, Arezoo Shajiei, Mohammad Hadi Sadeghian, et al.
Hematology/Oncology and Stem Cell Therapy (2016) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 67
The clinical mutatome of core binding factor leukemia
Sabrina Opatz, Stefanos A. Bamopoulos, Klaus H. Metzeler, et al.
Leukemia (2020) Vol. 34, Iss. 6, pp. 1553-1562
Open Access | Times Cited: 62
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
Anuradha Kirtonia, Gouri Pandya, Gautam Sethi, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 8, pp. 1069-1091
Closed Access | Times Cited: 57
MRD Tailored Therapy in AML: What We Have Learned So Far
Lok Lam Ngai, Angèle Kelder, Jeroen J.W.M. Janssen, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 52
Role of CBL Mutations in Cancer and Non-Malignant Phenotype
Davide Leardini, Daria Messelodi, Edoardo Muratore, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 839-839
Open Access | Times Cited: 29
FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
Shuping Li, Na Li, Yun Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future
Heike Aupperle‐Lellbach, Alexandra Kehl, Simone de Brot, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 5, pp. 199-199
Open Access | Times Cited: 6
Core‐binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy
Melhem Solh, Sophia Yohe, Daniel Weisdorf, et al.
American Journal of Hematology (2014) Vol. 89, Iss. 12, pp. 1121-1131
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top